USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sartorius Stedim Biotech GmbH

USPTO PatentsView assignee record - 237 granted patents across 88 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme).

RSS updates for this company

The verdict

According to USPTO PatentsView, Sartorius ranks #1,724 of 49,997 tracked US assignees by granted-patent volume, with 237 patents across 88 technology areas.

#1,724
of 49,997 US assignees by volume
Top 5%
by Innovation Score (58.3/100)
13.4
avg claims per patent
-13%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1724 · Foreign Corporation #1,724 · 237 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MID 237 grants
  • TOP-DECILE #1,724/49,997
  • PHOTO-FINISH AVL List
  • CPC-WIDE C12M · 88 areas
  • INNOV-PAR 58.3/100
  • CLAIMS-RICH 13.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -13% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: AVL List GMBH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Sartorius

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Sartorius's Innovation Score is 58.3/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Sartorius's grant cadence moved

Between 2020–2024, Sartorius Stedim Biotech GmbH received 103 grants versus 118 in 2015–2019 (-13% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2019 at 34 grants and bottomed in 2020 at 16. Lead class C12M accounts for 35.4% of the portfolio across 88 subclasses. Volume neighbours: AVL List GMBH (#1,721) and Alps Electric Co., Ltd. (#1,729).

Sartorius's three-year grant acceleration

From 2019–2021 to 2022–2024, Sartorius Stedim Biotech GmbH moved from 70 to 67 grants (0.96x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,301. See the growth leaderboard.

Who files at Sartorius's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Sartorius holds 237 patents at rank #1,725, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Sartorius

By rank, the assignees closest to #1,725 in granted patent volume.

Leaders in C12M (Apparatus FOR Enzymology OR Microbiology)

Other assignees with the most granted patents in Sartorius's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Sartorius, neither rank-band nor same-CPC leaders (those blocks stay above).

Sartorius's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1520253035 20152016201720182019202020212022202320242025 16
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Sartorius Stedim Biotech GmbH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 25 10.5%
2016 17 7.2%
2017 21 8.9%
2018 21 8.9%
2019 34 14.3%
2020 16 6.8%
2021 20 8.4%
2022 20 8.4%
2023 22 9.3%
2024 25 10.5%
2025partial year 16 6.8%

Which technologies does Sartorius Stedim Biotech GmbH patent most?

Top 15 of 88 technology areas

Where it ranks

Overall rank by patents

#1,724

of 49,997 tracked assignees

Innovation Score

58.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Sartorius Stedim Biotech GmbH's patent record in context - here's where to go next.

  • Sartorius Stedim Biotech GmbH's lead technology class is C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme), 35.4% of its portfolio - see every assignee active in that class. Explore C12M
  • Ranked #1,724 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Sartorius Stedim Biotech GmbH against AVL List GMBH, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 58.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.